| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |